The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Premature ovarian failure
Abstract
Premature ovarian failure (POF) causing hypergonadotrophic hypogonadism occurs in 1% of women. In majority of cases the underlying cause is not identified. The known causes include: (a) Genetic aberrations, which could involve the X chromosome or autosomes. A large number of genes have been screened as candidates for causing POF; however, few clear causal mutations have been identified. (b) Autoimmune ovarian damage, as suggested by the observed association of POF with other autoimmune disorders. Anti-ovarian antibodies are reported in POF by several studies, but their specificity and pathogenic role are questionable. (c) Iatrogenic following surgical, radiotherapeutic or chemotherapeutic interventions as in malignancies. (d) Environmental factors like viral infections and toxins for whom no clear mechanism is known. The diagnosis is based on finding of amenorrhoea before age 40 associated with FSH levels in the menopausal range. Screening for associated autoimmune disorders and karyotyping, particularly in early onset disease, constitute part of the diagnostic work-up. There is no role of ovarian biopsy or ultrasound in making the diagnosis. Management essentially involves hormone replacement and infertility treatment, the only proven means for the latter being assisted conception with donated oocytes. Embryo cryopreservation, ovarian tissue cryopreservation and oocyte cryopreservation hold promise in cases where ovarian failure is foreseeable as in women undergoing cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Growth differentiation factor-9 is required during early ovarian folliculogenesis
Dong, J., Albertini, D. F., Nishimori, K., Kumar, T. R., Lu, N., & Matzuk, M. M. (1996) · Nature · doi:10.1038/383531a0 · Cited by 1,646
The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4
Zimmerman, L. B., De Jesús-Escobar, J. M., & Harland, R. M. (1996) · Cell · doi:10.1016/s0092-8674(00)80133-6 · Cited by 1,633
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue
Donnez, J., Dolmans, M., Demylle, D., Jadoul, P., Pirard, C., Squifflet, J., Martinez-Madrid, B., & Van Langendonckt, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17222-x · Cited by 1,631
Brown, C. J., Ballabio, A., Rupert, J. L., Lafreniere, R. G., Grompe, M., Tonlorenzi, R., & Willard, H. F. (1991) · Nature · doi:10.1038/349038a0 · Cited by 1,533
Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80086-0 · Cited by 1,458
Germline stem cells and follicular renewal in the postnatal mammalian ovary
Johnson, J., Canning, J., Kaneko, T., Pru, J. K., & Tilly, J. L. (2004) · Nature · doi:10.1038/nature02316 · Cited by 1,278
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
LINDSTROM, J. M., SEYBOLD, M. E., LENNON, V. A., WHITTINGHAM, S., & DUANE, D. D. (1976) · Neurology · doi:10.1212/wnl.26.11.1054 · Cited by 1,186
Cited by
Intraovarian Control of Early Folliculogenesis
Hsueh, A. J. W., Kawamura, K., Cheng, Y., & Fauser, B. C. J. M. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1020 · Cited by 702
Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles
Adhikari, D., & Liu, K. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0048 · Cited by 481
The FMR1 premutation and reproduction
Wittenberger, M. D., Hagerman, R. J., Sherman, S. L., McConkie-Rosell, A., Welt, C. K., Rebar, R. W., Corrigan, E. C., Simpson, J. L., & Nelson, L. M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.09.004 · Cited by 412
How do chemotherapeutic agents damage the ovary?
Morgan, S., Anderson, R. A., Gourley, C., Wallace, W. H., & Spears, N. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms022 · Cited by 409
Contemporary genetic technologies and female reproduction
The Evian Annual Reproduction (EVAR) Workshop Group 2010, Fauser, B. C. J. M., Diedrich, K., Bouchard, P., Dominguez, F., Matzuk, M., Franks, S., Hamamah, S., Simon, C., Devroey, P., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr033 · Cited by 349
Beck-Peccoz, P., & Persani, L. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-9 · Cited by 319
Mutant Cohesin in Premature Ovarian Failure
Caburet, S., Arboleda, V. A., Llano, E., Overbeek, P. A., Barbero, J. L., Oka, K., Harrison, W., Vaiman, D., Ben-Neriah, Z., García-Tuñón, I., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309635 · Cited by 304
Oocyte cryopreservation: where are we now?
Argyle, C. E., Harper, J. C., & Davies, M. C. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw007 · Cited by 291
Kalantaridou, S. N., Naka, K. K., Papanikolaou, E., Kazakos, N., Kravariti, M., Calis, K. A., Paraskevaidis, E. A., Sideris, D. A., Tsatsoulis, A., Chrousos, G. P., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0015 · Cited by 284
Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure
Laissue, P., Christin-Maitre, S., Touraine, P., Kuttenn, F., Ritvos, O., Aittomaki, K., Bourcigaux, N., Jacquesson, L., Bouchard, P., Frydman, R., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02135 · Cited by 280
Potential Options for Preservation of Fertility in Women
Lobo, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043475 · Cited by 268
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency
Visser, J. A., Schipper, I., Laven, J. S. E., & Themmen, A. P. N. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.224 · Cited by 264
Cohen, J., Chabbert-Buffet, N., & Darai, E. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0595-y · Cited by 256
Silber, S. J., DeRosa, M., Pineda, J., Lenahan, K., Grenia, D., Gorman, K., & Gosden, R. G. (2008) · Human Reproduction · doi:10.1093/humrep/den032 · Cited by 255
Menopause in Type 1 Diabetic Women
Dorman, J. S., Steenkiste, A. R., Foley, T. P., Strotmeyer, E. S., Burke, J. P., Kuller, L. H., & Kwoh, C. K. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1857 · Cited by 171
Xu, X., Chen, X., Zhang, X., Liu, Y., Wang, Z., Wang, P., Du, Y., Qin, Y., & Chen, Z.-J. (2016) · Human Reproduction · doi:10.1093/humrep/dew283 · Cited by 109
Prenatal Determinants of Uterine Volume and Ovarian Reserve in Adolescence
Hart, R., Sloboda, D. M., Doherty, D. A., Norman, R. J., Atkinson, H. C., Newnham, J. P., Dickinson, J. E., & Hickey, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1342 · Cited by 57
Hormone replacement therapy and women with premature menopause–a cancer survivorship issue
King, J., Wynne, C. H., Assersohn, L., & Jones, A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.007 · Cited by 34
Metadata
- Authors
- Goswami, D., & Conway, G. S.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-26
- Volume
- 11
- Issue
- 4
- Pages
- 391-410
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2109299391
- Cited by
- 713
- References
- 211
- FWCI
- 31.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.